Wishing you peace, prosperity, and plenty of turkey, mashed potatoes, and pumpkin pie! Happy Thanksgiving from the Previse team! We are truly grateful for all of you! #grateful #happy #thanksgiving #friends #family #makingmemories
Previse
生物技术研究
Previse is on a mission to save lives through the prediction and earlier detection of cancer.
关于我们
Previse is on a mission to save lives through the earlier detection and prevention of cancer, starting with esophageal cancer. They are actively working to get patients and healthcare providers the answers they need sooner by understanding and unlocking the power of biomarkers on cancer development and severity. Previse’s technology was made possible by grants from the National Institutes of Health (“NIH”) and developed after decades of research by the GI Early Detection Biomarker Lab at the Johns Hopkins University School of Medicine. An esophageal cancer diagnosis is something that nobody wants to hear. Today, this cancer takes 16,000 lives in the United States each year. The primary reason - the current detection method, upper endoscopy, is both invasive and expensive, so it's often not used until symptoms arise. In over 75% of cases, this is after the cancer has already spread and treatment options are limited, leading to esophageal cancer being the 3rd most lethal cancer in the United States (behind only pancreatic and lung cancer). Previse's early-detection system combines a simple routine test given as part of routine care with our patented DNA biomarkers that accurately test for disease. Our system is convenient, inexpensive, and accurate, so it can be given to those at risk before cancer symptoms, empowering patients to know earlier, receive necessary treatments, and live a healthier, longer life.
- 网站
-
https://www.previsedx.com/
Previse的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Baltimore
- 类型
- 私人持股
- 创立
- 2018
- 领域
- diagnostics、medical device、medicine、early detection和medtech
地点
-
主要
获取路线
US，Baltimore
Previse员工
动态
-
?? It's GERD Awareness Week! ?? Gastroesophageal reflux disease or "GERD" is much more common than you might think. GERD affects as many as 1 in 5 individuals (men AND women) and has the ability to cause significant damage to your esophagus if left untreated. If you're experiencing any of the symptoms below or similar (note: this is not an exhaustive list) or have concerns about how to get your symptoms or diagnosis under control, reach out to your physician for more information about treatment options. #gerdawarenessweek #gerdisreal #gi #esophagealcancer #barrettsesophagus #raisingawareness #hearburn #reflux #gerd
-
-
We would like to sincerely thank Jordan Davidson, Stephen J. Meltzer, MD, Seth Gross, MD, and everyone at Gastroenterology & Endoscopy News for their contributions this month's article highlighting publication of the Esopredict clinical validation study. The article features study results, provides thoughtful GI specialist input, and offers insights about pairing DNA methylation science with biomarkers to risk stratify and inform care of patients with Barrett's esophagus. #gastroendonews #gi #barrettsesophagus #riskstratification #tailoringcare #biomarkers #moleculardiagnostics Learn more about Previse and Esopredict here: https://previsedx.com
-
THANK YOU to our veterans-all the brave men and women who have served and sacrificed so much to keep us safe and secure. We appreciate and honor everything you do at home and abroad to keep the flame of freedom burning bright. Be sure to thank a veteran today! #freedom #veterans #thankavet #honor #courage #sacrifice #service #freedomisntfree
-
-
The American College of Gastroenterology Annual Scientific Meeting is officially underway in Philadelphia, PA where our colleagues Daniel Lunz and Sarah Laun PhD presented data yesterday from the Esopredict decision impact study and fielded questions from attendees. Our presenters also received an award for outstanding poster presentation, capping a day filled with dynamic educational exchange and idea sharing! Congratulations Team Previse! #acg2024 #innovation #clinicalresearch #changingtheparadigm #patientcenteredcare #gi #barrettsesophagus #gastroenterology #prevention https://lnkd.in/gXbZer3y
-
-
This $1.8M NIH award will accelerate the development of a non-endoscopic screening test for esophageal cancer, including a highly lethal subtype known as esophageal squamous cell carcinoma (ESCC). The funds will also underpin early commercialization efforts in the U.S. and establish a commercialization pathway in?East Africa, ensuring global access to accurate, affordable, and practical esophageal cancer detection. #esophagealcancer #prevention #detection #gi #barrettsesophagus #changingtheparadigm #healthcareinnovation #Baltimore #lifesciences #epigentics https://lnkd.in/gAxaCpQK
-
?? ?? Our very own CEO, Daniel Lunz, has earned a well deserved spot as a member of the Baltimore Business Journal's "40 Under 40" Class of 2024! Dan's steadfast commitment to supporting his team, family, and hometown Baltimore community inspires us daily to reach new heights in our efforts to advance the health of the patients and healthcare providers we serve. Beyond his professional and personal achievements, Dan is a also a US Marine veteran who has served as a long time mentor at Helping Up Mission and volunteer who helps other US Veterans transition back to civilian life. He is at the heart of what it means to be a difference maker. ?? Congratulations, Dan, on this outstanding achievement! ??
-
-
?? The American College of Gastroenterology 2024 Annual Scientific Meeting and Postgraduate Course is less than 10 days away and the Previse team is excited to get connected with friends old and new! ?? Stop by and say hi to Daniel Lunz, Ryan Brennan, and Sarah Laun PhD at our upcoming poster session or feel free to message us via Linked In or the ACG meeting app. ?? We look forward to seeing you in the heart of Philadelphia, PA! #ACG2024 #Gastroenterology #GI #Innovation #Scientificbreakthrough #Precisionmedicine #Philadelphia #Previsedx
-
-
?? Happy #PAweek! ?? Join the Previse team as we celebrate the more than 178,700 PAs across the U.S. who dedicate themselves 365 days per year to delivering quality care to patients and the communities they serve. @aapaorg #PAsGoBeyond #qualitycare #dedication #compassion #healthcareheroes
-
-
?? Today we celebrate World Cancer Research Day ?? and the tireless work being done globally to drive advances across the cancer spectrum through development of effective prevention, early detection, and therapeutic strategies. At Previse, we are on a mission to provide patients living with pre-cancerous Barrett's esophagus and their GI physicians with accurate, actionable information that can be used to stratify their future cancer risk and optimize their unique BE care plans. We live out this mission daily because we believe everyone deserves to enjoy a long life filled with more smiles, more laughter, and more joy filled moments that don't include a cancer diagnosis. Learn more about Previse and Esopredict at https://previsedx.com/ #worldcancerresearchday #drivingchange #innovation #scientificresearch #lifechanging #changetheparadigm #gi #gastroenterology #barrettsesophagus
-